"RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes", a collaborative work between Janssen and ULUND resulting in a comprehensive 10 Minutes tutorial just published in Endocrinology, Diabetes & Metabolism
A publication from the UOXF team discussing the potential mechanisms through which diabetes may affect the risk of more severe outcomes in Covid-19 and how diabetic emergencies and longer term pathology may be aggravated by infection with the virus. Read the article.
Today took place the 5th RHAPSODY Consortium Meeting. An unusual online format that didn't affect the quality of the scientific exchanges. Despite the difficult conditions of the last few months the project remains on track.
One year before the end of the project we took stock of the results so far and discussed the necessary steps for a successful project conclusion.